📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-11 16:16
0 analysed today
FollowTelegram
0
Today
149,939
All-time analysed
42,983
Positive
6,669
Negative
91,579
Neutral
8,640
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Rs 64.89 Cr Q1 Net Profit; Real Estate Revenue Stable at Rs 37.03 Cr
Alembic Limited reported a consolidated net profit of Rs 64.89 Cr for Q1 FY27, a 5.3% increase from Rs 61.64 Cr in the same quarter last year. This growth was primarily driven by a higher share of profit from its associate company (Alembic Pharmaceuticals), which contributed Rs 49.19 Cr (75.8% of total profit). Consolidated revenue from operations remained nearly flat at Rs 48.74 Cr compared to Rs 49.75 Cr YoY. The core Real Estate segment contributed Rs 37.03 Cr to revenue, while the API segment saw a decline in profit to Rs 1.66 Cr.
Confidence: HIGH
What changedThe company reported its first-quarter results for FY27, showing steady performance in real estate but a reliance on associate profits for net income growth.
Why it mattersAlembic Ltd functions partly as a holding company for its stake in Alembic Pharma; its standalone value is tied to its niche real estate developments in Vadodara.
Consolidated Revenue (Q1): Rs 48.74 CrConsolidated Net Profit (Q1): Rs 64.89 CrAssociate Profit Contribution: Rs 49.19 CrReal Estate Segment Profit: Rs 13.98 CrDisputed Electricity Duty Provision: Rs 20.52 Cr
📅 Short termThe stock is likely to remain neutral in the short term as the results are largely in line with historical trends without major surprises.
📈 Long termLong-term value depends on the successful development of the 'Alembic City' project and the continued dividend/profit flow from its pharmaceutical associate.
⚠ Risk flags
- High dependence on associate company profits (Alembic Pharma)
- Pending legal dispute regarding electricity duty (Rs 20.52 Cr principal)
- API segment margin contraction
Key Highlights
Consolidated Net Profit increased 5.3% YoY to Rs 64.89 Cr for the quarter ended June 30, 2026.
Share of profit from associate company rose to Rs 49.19 Cr from Rs 43.84 Cr in the previous year's quarter.
Real Estate segment revenue was stable at Rs 37.03 Cr, contributing 76% of total operational revenue.
API segment revenue declined to Rs 11.71 Cr from Rs 12.95 Cr YoY, with segment profit dropping 39% to Rs 1.66 Cr.
Company maintains a provision of Rs 20.52 Cr for a disputed electricity duty matter currently with the Supreme Court.
👀 What to Watch
Monitor the quarterly performance of Alembic Pharmaceuticals, as it remains the primary driver of Alembic Ltd's consolidated bottom line. Watch for updates on the monetization of the 102-acre Vadodara land bank for standalone growth.
Alembic Ltd Reports FY26 Net Profit of Rs 317.38 Cr, Recommends Rs 2.40 Dividend
Alembic Limited reported a consolidated net profit of Rs 317.38 crore for FY26, a marginal increase from Rs 310.68 crore in the previous fiscal. The Board has recommended a final dividend of Rs 2.40 per share (120%), maintaining the payout level from the previous year. While total revenue from operations grew by 8% to Rs 239.99 crore, the API segment showed robust growth of 44.6%. However, Profit Before Tax saw a slight decline to Rs 148.76 crore due to increased employee benefit expenses and material costs.
Key Highlights
Consolidated Net Profit for FY26 rose to Rs 31,738 Lakhs from Rs 31,068 Lakhs in FY25.
Recommended a final dividend of Rs 2.40 per equity share of face value Rs 2 each.
API business revenue grew significantly by 44.6% to Rs 4,659 Lakhs from Rs 3,221 Lakhs YoY.
Real Estate segment revenue remained stable at Rs 19,340 Lakhs compared to Rs 18,967 Lakhs in the previous year.
Full-year Earnings Per Share (EPS) improved slightly to Rs 12.36 from Rs 12.10.
👀 What to Watch
The company remains a steady dividend payer with stable consolidated earnings, though investors should monitor the stagnation in the core real estate segment. Keep a watch on the legal contingency regarding the disputed electricity duty liability of Rs 2,052.13 lakhs.
Alembic Ltd FY26 Consolidated Net Profit Rises to ₹317.38 Cr; Recommends ₹2.40 Dividend
Alembic Limited reported a consolidated net profit of ₹31,738 Lakhs for FY26, a marginal increase of 2.1% compared to ₹31,068 Lakhs in FY25. The results were significantly supported by the share of profit from its associate, Alembic Pharmaceuticals, which contributed ₹19,145 Lakhs. Revenue from operations grew 8.1% YoY to ₹23,999 Lakhs, primarily driven by the Real Estate segment which accounts for over 80% of total revenue. The company maintained its dividend payout at ₹2.40 per share, consistent with the previous year.
Key Highlights
Consolidated Net Profit for FY26 stood at ₹31,738 Lakhs versus ₹31,068 Lakhs in FY25.
Revenue from operations increased to ₹23,999 Lakhs from ₹22,189 Lakhs in the previous fiscal.
Real Estate segment contributed ₹19,340 Lakhs to revenue with a segment profit of ₹8,117 Lakhs.
API business revenue grew to ₹4,659 Lakhs, up from ₹3,221 Lakhs in FY25.
Board recommended a dividend of ₹2.40 per equity share (120% of face value of ₹2).
👀 What to Watch
Investors should monitor the Real Estate segment's execution as it remains the primary revenue driver, while also tracking Alembic Pharma's performance which heavily influences the bottom line. The steady dividend provides a decent yield, but core standalone profit growth remains modest.
Alembic Ltd Q3 Revenue Up 28% YoY to ₹74.34 Cr; API Segment Revenue Doubles
Alembic Limited reported a consolidated revenue of ₹74.34 crore for Q3 FY26, marking a 28.3% growth compared to ₹57.92 crore in the same period last year. Net profit (including share of associates) stood at ₹60.13 crore, a slight decline from ₹65.39 crore YoY, impacted by higher construction costs and a ₹1.43 crore provision for new labour codes. The API segment showed robust growth, with revenue surging 116% YoY to ₹13.50 crore. However, a significant negative swing in Other Comprehensive Income led to a total comprehensive loss of ₹56.84 crore for the quarter.
Key Highlights
Consolidated Revenue from Operations increased 28.3% YoY to ₹74.34 crore.
API business revenue surged 116% YoY to ₹13.50 crore from ₹6.25 crore.
Real Estate segment revenue grew to ₹60.84 crore compared to ₹51.67 crore in the previous year's quarter.
Net Profit after tax (including associate share) declined 8% YoY to ₹60.13 crore.
Company made a provision of ₹143.72 lakhs towards the implementation of four new Labour Codes.
👀 What to Watch
Investors should focus on the strong momentum in the API segment and steady real estate performance, while remaining cautious about the volatility in total comprehensive income caused by investment valuation changes.
